Overall, IDO1 expression in both APCs and melanoma cells correlates with poor prognosis [58], and IDO enzymes appear to have an influence on the immune system in terms of recognizing melanoma cells and setting up an early response, thus promoting tumor immune evasion and cancer spread. Here, IDO1 is linked to neoplasm.